KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Operating Expenses (2020 - 2025)

Organon has reported Operating Expenses over the past 6 years, most recently at $531.0 million for Q4 2025.

  • Quarterly results put Operating Expenses at $531.0 million for Q4 2025, down 12.66% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (down 28.67% YoY), and the annual figure for FY2025 was $2.2 billion, down 3.45%.
  • Operating Expenses for Q4 2025 was $531.0 million at Organon, up from $499.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for OGN hit a ceiling of $1.5 billion in Q4 2023 and a floor of $499.0 million in Q3 2025.
  • Median Operating Expenses over the past 5 years was $1.2 billion (2021), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Operating Expenses: soared 40.53% in 2021 and later tumbled 64.42% in 2024.
  • Organon's Operating Expenses stood at $1.4 billion in 2021, then increased by 0.51% to $1.4 billion in 2022, then rose by 8.73% to $1.5 billion in 2023, then tumbled by 59.3% to $608.0 million in 2024, then dropped by 12.66% to $531.0 million in 2025.
  • The last three reported values for Operating Expenses were $531.0 million (Q4 2025), $499.0 million (Q3 2025), and $550.0 million (Q2 2025) per Business Quant data.